4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000063
Chief Financial Officer sold 3,141 shares at $34.71 ($109,024)
- Chief Financial Officer acquired 8,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jones Cecilia · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,500 | 58,139 | D | ||
| 2026-04-02 | Sale : show line 2 in the form 10b5-1 | −3,141 | $34.71 | $109,024 | 54,998 | D |
| Open-market sales · 3,141 sh · avg $34.71 · $109,024 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-02 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −8,500 | 8,500 | D |
Loading xslF345X06/wk-form4_1775506133.xml…